The track spans an extensive two-day agenda, covering key aspects of biologics & biosimilars in depth. It will delve into critical areas such as innovation, technology, regulatory frameworks, strategy and commercialization.
This will be a one-day track and will emphasize on Cell & Gene Therapy: Innovation, technology, clinical trials, regulatory, supply chain, and commercialization.
The track spans an extensive two-day agenda, covering the bioprocessing & biomanufacturing aspects of biologics/biosimilars in detail.